
Danica Marrelli, OD, FAAO, shares key highlights from her presentation, which she presented during the Glaucoma 360 meeting held this year in San Francisco.

Danica Marrelli, OD, FAAO, shares key highlights from her presentation, which she presented during the Glaucoma 360 meeting held this year in San Francisco.

Second global virtual event on myopia management scheduled for February 16, 2023.

As our dependence on technology progresses, we have seen tremendous impact on all aspects of our lives—including our kids’ eyes and vision.

Three experts in myopia control convened at the Optometry Times EyeCon meeting to discuss methods to control this burgeoning global epidemic.

Research indicates that too much technology usage results in negative effects on eyesight.

Enhanced treatments, tools, and resources make a difference.

Contact lenses can be beneficial for children, even when not medically necessary, explains Jennifer Fogt, OD, FAAO, FSLS.

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Vitto Mena, Jr., OD, MS, shares highlights from his discussion titled, "Contact lenses for kids: concepts and methods for contemporary care," which he co-presented during the 2022 American Academy of Optometry meeting.

When interpreting study findings, take into consideration the similarity and the differences between the subjects recruited for the study versus the patient population each practitioner serves.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.

In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.

Eyecare practitioners' top misconceptions just may surprise you.

Johnson & Johnson Vision receives FDA-approval of lens parameter expansion for their ACUVUE Abiliti Overnight Therapeutic Lenses for Myopia Management.

Clinical pilot study evaluates effect after 1 month of wear.

Alexis Malkin, OD, FAAO, highlights her Vision Expo West 2022 presentation titled, "Expand your practice: how to integrate low vision into everyday patient care and improve outcomes."

Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia

Valerie M. Kattouf, OD, shares key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."

Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.

Clinical pilot study evaluates effect after 1 month of wear.

Researchers in Tokyo found that nearly 50% of preschoolers are myopic, indicating that the disease has reached epidemic proportions.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.

Healthy digital media habits make a healthy child.

Studies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.